Citadel Advisors
MDXG icon

Citadel Advisors’s MiMedx Group MDXG Stock Holding History

Citadel Advisors’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$142K Buy
35,900
+12,000
+50% +$60.4K ﹤0.01% 11731
2025
Q4 		$162K Sell
23,900
-33,800
-59% -$237K ﹤0.01% 11229
2025
Q3 		$403K Buy
+57,700
New +$401K ﹤0.01% 9653
2025
Q2 		– Sell
-8,900
Closed -$67.6K – 14044
2025
Q1 		$67.6K Sell
8,900
-11,100
-56% -$92.7K ﹤0.01% 11963
2024
Q4 		$192K Sell
20,000
-18,300
-48% -$143K ﹤0.01% 10518
2024
Q3 		$226K Sell
38,300
-68,300
-64% -$452K ﹤0.01% 9893
2024
Q2 		$739K Buy
106,600
+82,800
+348% +$582K ﹤0.01% 7246
2024
Q1 		$183K Buy
23,800
+5,500
+30% +$44.2K ﹤0.01% 10450
2023
Q4 		$160K Sell
18,300
-37,100
-67% -$272K ﹤0.01% 10281
2023
Q3 		$404K Buy
55,400
+15,300
+38% +$114K ﹤0.01% 8532
2023
Q2 		$265K Buy
40,100
+25,300
+171% +$129K ﹤0.01% 9310
2023
Q1 		$50.5K Sell
14,800
-2,600
-15% -$10.1K ﹤0.01% 12128
2022
Q4 		$48.4K Sell
17,400
-18,600
-52% -$55.6K ﹤0.01% 12186
2022
Q3 		$103K Sell
36,000
-12,600
-26% -$44.8K ﹤0.01% 11066
2022
Q2 		$169K Buy
48,600
+13,100
+37% +$51.3K ﹤0.01% 10862
2022
Q1 		$167K Buy
35,500
+7,400
+26% +$36.2K ﹤0.01% 11733
2021
Q4 		$170K Sell
28,100
-14,800
-34% -$103K ﹤0.01% 12097
2021
Q3 		$260K Buy
42,900
+8,000
+23% +$90.2K ﹤0.01% 11388
2021
Q2 		$437K Sell
34,900
-21,800
-38% -$236K ﹤0.01% 10363
2021
Q1 		$584K Buy
56,700
+29,200
+106% +$282K ﹤0.01% 9343
2020
Q4 		$250K Buy
+27,500
New +$198K ﹤0.01% 9394
2018
Q4 		– Sell
-75,600
Closed -$467K – 9508
2018
Q3 		$467K Buy
75,600
+20,800
+38% +$94K ﹤0.01% 6814
2018
Q2 		$350K Sell
54,800
-63,600
-54% -$453K ﹤0.01% 6950
2018
Q1 		$825K Buy
118,400
+95,000
+406% +$1.11M ﹤0.01% 5087
2017
Q4 		$295K Sell
23,400
-4,300
-16% -$52.4K ﹤0.01% 6492
2017
Q3 		$329K Buy
+27,700
New +$411K ﹤0.01% 5922
2016
Q3 		– Sell
-16,400
Closed -$131K – 7539
2016
Q2 		$131K Buy
+16,400
New +$128K ﹤0.01% 6079
2016
Q1 		– Sell
-10,200
Closed -$96K – 7481
2015
Q4 		$96K Sell
10,200
-11,200
-52% -$97K ﹤0.01% 6738
2015
Q3 		$207K Sell
21,400
-900
-4% -$9.5K ﹤0.01% 6098
2015
Q2 		$258K Buy
22,300
+1,200
+6% +$12.3K ﹤0.01% 5963
2015
Q1 		$219K Buy
21,100
+16,100
+322% +$151K ﹤0.01% 6068
2014
Q4 		$58K Buy
+5,000
New +$49.4K ﹤0.01% 7083
2014
Q3 		– Sell
-600
Closed -$4K – 8285
2014
Q2 		$4K Buy
+600
New +$3.51K ﹤0.01% 7760

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Citadel Advisors's MDXG Position: Q1 2026 in Review

Citadel Advisors increased its MiMedx Group (MDXG) stake by 73% in Q1 2026, buying an estimated $1.65M and bringing the position to 776,441 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #5221.

Citadel Advisors first reported a position in MDXG in Q3 2013 and has held it in 36 quarters since. The position peaked at $4.47M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Citadel Advisors held 776,441 shares of MiMedx Group worth $3.07M as of Q1 2026.
  • Citadel Advisors bought 326,779 MiMedx Group shares in Q1 2026, an estimated $1.65M.
  • MiMedx Group made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5221 holding.
  • Citadel Advisors first reported a position in MiMedx Group in Q3 2013 and has held it in 36 quarters since.
  • Citadel Advisors's MiMedx Group position peaked at $4.47M in Q3 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.